Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

about

Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis.

P2860

Q35956262-262B7181-F07F-4DBC-8D4F-97A6F63CA868

P2860

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

Item

http://www.wikidata.org/entity/Q42109528

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@en

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@nl

type

Item

label

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@en

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@nl

prefLabel

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@en

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@nl

P1476

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

@en

P2093

P Hande Ozdinler

http://www.w3.org/2001/XMLSchema#string

Richard B Silverman

http://www.w3.org/2001/XMLSchema#string

P2860

State of play in amyotrophic lateral sclerosis genetics

The past, present and future of stem cell clinical trials for ALS

eGFP expression under UCHL1 promoter genetically labels corticospinal motor neurons and a subpopulation of degeneration-resistant spinal motor neurons in an ALS mouse model.

Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.

Toward more efficient clinical trials for amyotrophic lateral sclerosis.

Clinical implications of recent breakthroughs in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis: Problems and prospects.

Moving forward in clinical trials for ALS: motor neurons lead the way please.

Advances in treating amyotrophic lateral sclerosis: insights from pathophysiological studies.

The non-cell-autonomous component of ALS: new in vitro models and future challenges.

P304

1179-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1021/ML500404B

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268793174

http://www.w3.org/2001/XMLSchema#string

P698

25408825

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

4233364

http://www.w3.org/2001/XMLSchema#string

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

about

P2860

P2860

Treatment of amyotrophic lateral sclerosis: lessons learned from many failures.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932